Improving survival rates of patients with light-chain cardiac amyloidosis in recent years

11 May 2024 (08:00 - 20:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Takeru Nabeta

Kitasato University School of Medicine, Sagamihara (Japan)

5 More presentations in this session

Presentation thumbnail

SGLT2 inhibitors in wild-type transthyretin amyloid cardiomyopathy: what to expect?

Doctor L. Pinheiro (Guimaraes, PT)

Abstract Slides Video

Presentation thumbnail

Therapeutic value of spironolactone in wild-type transthyretin amyloid cardiomyopathy

Doctor L. Pinheiro (Guimaraes, PT)

Abstract Slides Video

Presentation thumbnail

Stabilizers of transthyretin in amyloid cardiomyopathy: a systematic review and meta-analysis.

Ms L. Burgos (Buenos Aires, AR)

Abstract Slides Video

Presentation thumbnail

Incidence and progression of left ventricular involvement in patients with arrythmogenic cardiomyopathy

Doctor A. Diaz Exposito (Malaga, ES)

Abstract Slides Video

Presentation thumbnail

Left ventricular non compaction in sub-saharan african adults

Doctor N. GAYE (Dakar, SN)

Abstract Slides Video

Access the full session

Session thumbnail

ePosters in myocardial disease 1

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024

You may be interested in

Congress Presentation

Impact of the non-invasive diagnostic algorithm on clinical presentation and prognosis in a nationwide multicentric light-chain and transthyretin-related cardiac amyloidosis cohort

Congress Presentation

Delays in diagnosis and treatment initiation of ATTR cardiac amyloidosis: a real-world data analysis

Congress Presentation

Improving early mortality risk detection in light-chain cardiac amyloidosis patients with routine echocardiographic indicators and mayo staging

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources